The control operated by the cell cycle machinery on MEF2 stability contributes to the downregulation of CDKN1A and entry into S phase.
about
MEF2 transcription factors: developmental regulators and emerging cancer genesThe different roles of selective autophagic protein degradation in mammalian cellsCoordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expressionDeregulation of F-box proteins and its consequence on cancer development, progression and metastasis.The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness.The Forkhead Transcription Factor FOXP2 Is Required for Regulation of p21WAF1/CIP1 in 143B Osteosarcoma Cell Growth Arrest.Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells.Potent and Selective Non-hydroxamate Histone Deacetylase 8 Inhibitors.MEF2C-MYOCD and Leiomodin1 Suppression by miRNA-214 Promotes Smooth Muscle Cell Phenotype Switching in Pulmonary Arterial HypertensionAn update on the implications of cyclin D1 in oral carcinogenesis.N-cadherin restrains PTH repressive effects on sclerostin/SOST by regulating LRP6-PTH1R interaction.Transformation by different oncogenes relies on specific metabolic adaptations.Alternative Splicing of Transcription Factors Genes in Muscle Physiology and Pathology.MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia.A population of G2-arrested cells are selected as sensory organ precursors for the interommatidial bristles of the Drosophila eye.Dynamic Phosphorylation of the Myocyte Enhancer Factor 2Cα1 Splice Variant Promotes Skeletal Muscle Regeneration and Hypertrophy.
P2860
Q26778515-20C1671C-A216-47B0-943E-86AA370CAFA6Q26785503-B2E7A49D-E3B3-4C27-B075-A225CF52A23AQ28067573-370B3968-2518-44B1-BC64-820A7301F356Q30278581-6931E90F-471C-4069-A1EE-41CBF5AA4134Q33626781-78F1C023-E3AE-4CBB-8454-867F4A6FFC4DQ35649604-48E1B756-CA81-40FD-85D0-B1CCF9C7C88BQ36446188-81958313-6456-4B80-A3DD-332FF725F107Q38730477-73A09B5C-3507-495A-AAF0-4B79CC9B4931Q38773231-61CDE630-1656-438F-A6CB-79475DE1FA7AQ38782834-2D7D6407-F7D1-4D49-88F4-6F1B3E51A9FEQ39305265-09098D91-B450-4DD7-BF2D-1C8972ACE14DQ41352726-7355DBD8-456B-47E4-BE6B-A4824222ABEDQ49798217-C84ACB10-CAE2-4E41-B6A1-6A0AF13F82E6Q50066248-02D71C54-29F0-455C-8E16-4D71D412DD62Q50434087-D2008CB6-8F96-47DF-8D05-E4DF5FBE8C37Q51525291-C75ECE6E-B47D-4E66-9325-9DA9C4DDAFDC
P2860
The control operated by the cell cycle machinery on MEF2 stability contributes to the downregulation of CDKN1A and entry into S phase.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The control operated by the ce ...... CDKN1A and entry into S phase.
@en
type
label
The control operated by the ce ...... CDKN1A and entry into S phase.
@en
prefLabel
The control operated by the ce ...... CDKN1A and entry into S phase.
@en
P2093
P2860
P356
P1476
The control operated by the ce ...... CDKN1A and entry into S phase.
@en
P2093
Andrea Clocchiatti
Enrico Gagliostro
Eros Di Giorgio
P2860
P304
P356
10.1128/MCB.01461-14
P407
P577
2015-03-02T00:00:00Z